New Delhi Metallo-β-Lactamase and Multidrug Resistance: A Global SOS? | Zendy

Robert A. Bonomo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

New Delhi Metallo-β-Lactamase and Multidrug Resistance: A Global SOS?

Author(s) -

Robert A. Bonomo

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciq179

Subject(s) - medicine , multiple drug resistance , new delhi , microbiology and biotechnology , drug resistance , biology , pathology , metropolitan area

extended-spectrum b-lactamase (ESBL)‐ or AmpC-producing gram-negative bacteria. At that time, only a few b-lactamases could inactivate carbapenems, and these were limited to rare strains of Enterobacter cloacae possessing serine carbapenemases called NMC-A (Non Metallo Carbapenmase-A) and IMI-1 (Imipenemase-I), Sme-1 (Serratia marcescens), MBLs BcI and BcII of Bacillus cereus, the MBL L1 of Stenotrophomonas maltophilia, and CcrA of Bacteroides fragilis (another MBL) [3]. In

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research